LXRP’s DehydraTECH has been shown to outperform conventional cannabis formulations and deliver 475 percent more CBD to the bloodstream in the first 15 minutes Compared to other industry formulations, DehydraTECH delivered cannabinoids quicker at industry-leading…
VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF) on Wednesday announced the results of its annual general and special meeting of shareholders held on June 4, 2019. According to the update, VIVO Cannabis shareholders approved a number…
Clinical-stage, gene-therapy company Genprex (NASDAQ: GNPX) is developing Oncoprex immunogene therapy as an innovative, gene therapy-based approach for the treatment of non-small cell lung cancer (“NSCLC”). An article further discussing the company reads, “NSCLC is…
LXRP has expanded its cannabis product relationship with Nuka Enterprises’ 1906 brand DehydraTECH enables 1906 chocolates to deliver on both function and flavor The company is expecting a tenfold increase in sales with expansion to…
INmune Bio Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, on Tuesday announced that its director of neuroscience, CJ Barnum, Ph.D., will be…
H1 2019 results reflect excellent operational execution: lowest cost of cultivation per gram among publicly reporting Canadian LPs, industry-leading adjusted gross margin and adjusted EBITDA (positive adjusted EBITDA for 3rd consecutive quarter in Q2 2019)…
Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) today announced that it has entered an arm’s length definitive agreement to acquire all of the issued and outstanding shares of capital stock of Spring…
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) this morning announced that it has identified improved performance features of a new version of the DehydraTECH(TM) delivery platform primarily suitable for…
Global technology and value-added solutions group Net Element (NASDAQ: NETE) today announced that it has launched Blade, its proprietary, fully-automated underwriting solution with predictive scoring powered by artificial intelligence (“AI”). Per the update, Blade is…
A presentation by INMB co-founder and CFO David Moss is slated for June 5 at 10:20 a.m., with one-on-one meetings also available The company’s active drug candidates are INKmune and INB03, which may be used…
TransCanna Holdings (CSE: TCAN) (FSE: TH8) today announced that its wholly owned subsidiary, TCM Distribution, Inc., has received an adult use cannabis manufacturing permit and an adult use cannabis distribution permit from the City of…
The global precision medicine market is expected to reach revenues of over $216.75 billion by 2028, propelled by a growing interest in personalized approaches to disease treatments and the application of new technologies Precision Therapeutics…
The CFO of CIIX’s CBD Biotechnology Co. Ltd. is scheduled to speak at the microcap conference The company official is expected to share exciting new developments related to its hemp product line with current and…
The company is now able to fulfill inquiries about white labeling its full-spectrum cannabinoids line ETST has added markets for CBD products through two distribution agreements The company continues to eye product placement in large…
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), a leading licensed producer of cannabis, today announced that its recreational cannabis plants and growing processes have been certified organic with Pro-Cert Organic Systems Ltd. According to the update,…
Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) today announced, further to its February 6, 2019 news release, that it will effect on June 3, 2019 the distribution of…
Cannabis Strategic Ventures (OTCQB: NUGS) today announced the strategic direction of NUGS Farm North, its wholly owned and operated flagship farm located in Northern California. Per the update, the six-acre, fully operational cultivation operation is…
Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) on Wednesday released its financial results for the third quarter ended March 31, 2019. Per the update, the company’s quarterly revenue at its Nevada cannabis…
INmune Bio is a diversified, clinical stage immunology company developing novel therapies targeting distinct parts of a patient’s innate immune system to fight disease Drug candidates INKmune and INB03 may be used to treat cancer;…
VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF) on Wednesday announced its Q1 2019 financial and operating results. Among the updates, the company outlined its strategy for continued capacity expansion and production capabilities, having doubled its annual…